Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-05-22

FDA Approved: FENOFIBRATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved Sun Pharmaceutical Industries, Inc.'s supplemental application for fenofibrate (generic) under ANDA 201748, authorizing the marketing of a generic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENOFIBRATE (Fenofibrate)

Snippet

SUPPL AP for FENOFIBRATE (FENOFIBRATE)